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THE MISSION OF THE  
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES 
 
The mission of the National Institute of General Medical Sciences (NIGMS) is to support basic 
biomedical research that is not targeted to specific diseases.  NIGMS funds studies on genes, 
proteins, and cells, as well as on fundamental processes like communication within and between 
cells, how our bodies use energy, and how we respond to medicines. NIGMS attempts to ensure 
the vitality and continued productivity of basic biomedical research, while producing the next 
generation of scientific breakthroughs and training the next generation of scientists.   
 
 
OVERVIEW OF NIGMS STRATEGY  
FOR ADDRESSING HEALTH DISPARITIES 
 
Throughout all of NIGMS’s research and research training programs, emphasis is placed on 
increasing the participation of underrepresented minorities in the biomedical research enterprise. 
One important consequence of a more diverse research community is likely to be increased 
attention to areas of research that can reduce health disparities. 
 
The areas of emphasis and the specific objectives that make up the NIGMS plan to reduce health 
disparities were suggested by members of the extramural science community through 
workshops, advisory council meetings, and other scientific meetings that NIGMS routinely holds 
to explore new areas of research and research training opportunities.  A draft of the plan was 
reviewed by the National Advisory General Medical Sciences Council and placed on the NIGMS 
website for comments.  Any feedback received has been used to revise the plan.   
 
 
RESEARCH 
 
Pharmacogenetics 
 
Rationale.  Pharmacogenetics is the effect of inheritance on drug action.  Individual variability 
occurs in both the desired therapeutic effects of drugs, as well as in their toxicity (or side 
effects).  In 1998, it was reported that adverse drug effects account for 100,000 deaths per year, 
as well as 5 to 10 percent of hospital admissions.  Some of these problems can be prevented 
through simple adjustments in medication choices or amounts, once the basic underlying 
scientific principles are understood.  The knowledge from basic research will help guide 
“personalized medicine”-the development of drug therapies intended to treat people as 
individuals.  
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Ethnogeographic differences in drug responses are known to exist between populations.  The 
best known instances are associated with the enzymes of drug clearance.  Genetic 
polymorphisms significantly affect the elimination of several major classes of important drugs in 
clinical use today, including antidepressants, antipsychotics, several cardiovascular drugs, 
antiepileptics, and anti-ulcer drugs.  For some of the enzymes involved in drug clearance, much 
less is known.  For example, it has been observed anecdotally that African-Americans frequently 
require higher doses of cyclosporine A, an immunosuppressant drug given for transplants and a 
substrate of an enzyme required to eliminate a very large proportion of medications in use today. 
However, the basis for the higher dosage requirement is not understood.  These genetic 
differences can have serious clinical consequences, particularly in chronic dosing situations.  
Knowledge that is acquired by studying the effects of inheritance in any selected groups can also 
be used to improve the health of individuals with similar genetic characteristics who are 
members of other population subgroups. 
 
Objective.  NIGMS’s Pharmacogenetics Initiatives are designed to discern the role that human 
genetic variation plays in drug responses.  The goal of the Pharmacogenetics Research Network 
and Knowledge Base is to systematically collect and interpret information about inherited 
variations in humans that determine both therapeutic and adverse responses to medications.  
Basic scientific knowledge will be stored in an information repository (the PharmGKB) that is 
intended for research purposes.  (For more information, see 
http://www.nih.gov/nigms/funding/pharmacogenetics.html) 
 
Action Plan:  Issue solicitations for proposals and award grants for 1) exploratory 
clinical studies to identify populations where functional genetic variation is believed to 
exist, and 2) the development of common resources for network usage, such as tissue 
sample banks, with samples obtained by appropriately informed consent.   
 
Performance Measure:  Solicitation of proposals and number of awards made.  NIGMS 
has announced the availability of supplements to promote exploratory clinical studies and 
to develop common resources for network usage (see NIH Guide notice 
NOT-GM-01-004, April 3, 2001).   
 
Outcome Measure:  The outcome anticipated from these supplements is new knowledge 
regarding the relationship between genetic variation and differential responses to 
pharmacological agents.  Significant findings from this research will be communicated 
through scientific conferences and publications. 
 
 
The NIGMS Human Genetic Cell Repository 
 
Rationale.  The NIGMS Human Genetic Cell Repository contains cell lines and DNA samples 
that allow investigators to study the causes of a large variety of genetic disorders, some of which 
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affect minority populations disproportionately.  Among these are samples for the study of adult 
onset diabetes, sickle cell anemia, and glucose-6-phosphate dehydrogenase deficiency.  The 
Repository also contains the DNA Polymorphism Discovery Resource, a set of 450 cell lines 
established in collaboration with the National Human Genome Research Institute, designed to 
reflect the genetic diversity of the U.S. population.   
 
Objective.  This resource enables investigators to identify DNA sequence polymorphisms, 
which serve as an important starting point in the search for genes involved in the etiology of 
complex genetic disorders.  Some of these complex genetic disorders, such as cardio- and 
cerebrovascular disease, hypertension, obesity, asthma, prostate cancer, end-stage renal disease, 
and systemic lupus erythematosus, occur disproportionately in African Americans.  The 
Repository will facilitate research on complex genetic disorders, furthering our understanding of 
these diseases and improving diagnosis and treatment. 
 
Action Plan:  Provide a resource for investigators studying the etiology, diagnosis, and 
treatment of genetic disorders by continuing support for the Human Genetic Cell 
Repository.   
 
Performance Measure:  Renewal of the contract for the Human Genetic Cell 
Repository.  The current contract for the Cell Repository will be maintained until 2003.  
NIGMS plans to continue funding the Repository beyond the current contract period. 
 
Outcome Measure:  Support for the Human Genetic Cell Repository is expected to 
facilitate research on genetic disorders, resulting in new knowledge published in 
scientific journals and presented at research conferences. 
 
 
Complex Genetic Diseases 
 
Rationale.  Heritable traits, including genetic disorders and susceptibility to disease, tend to arise 
and concentrate in specific populations, often in response to an environmental stress.  For 
example, there is strong evidence that the genes for genetic disorders, among them sickle cell 
anemia, Tay-Sachs disease, and cystic fibrosis, served in the past to protect populations from 
infectious diseases.  Genetic and environmental differences between populations, both present 
and past, are part of the equation that explains health disparities.   
 
Objective.  As more data on genetic and environmental differences become available, the 
challenge will be to interpret them correctly.  Studying the architecture of traits, particularly 
complex ones such as cardiovascular diseases, asthma, and obesity, that differ among 
populations requires the application of mathematical and statistical models that account for 
current genetic information and past population history.  Current models only account for a 
fraction of the information needed to fully understand the genetics of traits related to health 
disparities. 
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Action Plan:  Provide support for research to further understanding of the architecture of 
traits related to health disparities through mathematical and statistical approaches.  
Because this research is investigator-initiated, the portion of this that will be directly 
related to health disparities is not known in advance. 
 
Performance Measure:  The issuance of program announcements in this area and the 
funding of research on complex diseases. 
  
Outcome Measure:  The long-term outcome anticipated from these research grants is 
new knowledge to guide subsequent research and the development of more effective 
diagnostics and treatments.  Significant findings from this research will be communicated 
through scientific conferences and publications. 
 
 
INFRASTRUCTURE AND CROSS-CUTTING ISSUES 
(RESEARCH CAPACITY) 
 
Rationale.  One of the ways in which NIGMS addresses the issue of health disparities is through 
its programs to increase the number and capabilities of underrepresented minority biomedical 
scientists, some of whom can be expected to pursue research related to health disparities in 
minority populations.  The focal point for this effort within the Institute is the Division of 
Minority Opportunities in Research (MORE).  The MORE Division has three components:  the 
Minority Biomedical Research Support (MBRS) Branch, the Minority Access to Research 
Careers (MARC) Branch, and a section that handles special initiatives.   
 
The MBRS program has recently undergone reorganization and has experienced an increase in 
the number of institutions that are eligible for research and institutional development support due 
to their substantial minority student enrollments.  Along with this increase in the number of 
potential applicants for MBRS grants has been a rise in the average size of requested grant 
awards, making these grants comparable in size to most NIGMS research grants.  As a result, 
MBRS' needs have grown substantially, and NIGMS has allocated additional resources to it.  
The MBRS program comprises three subcomponents:  Support of Continuous Research 
Excellence (the SCORE program), the Research Initiative for Scientific Enhancement (RISE), 
and the Initiative for Minority Student Development (IMSD).   
 
Together, the MORE programs cover the educational spectrum from the undergraduate level to 
postdoctoral activities by providing support in two broad areas of need:  institutional 
development and training and career development.   
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Institutional Development 
 
Objective.  The goal of MORE's institutional development support is to enhance the science 
curricula and faculty research capabilities at institutions with substantial minority enrollments.   
 
Action Plan:  Continue to provide support for institutional development through the 
MBRS program.   
 
Performance Measure:  Number of MBRS grants awarded for institutional 
development.  
 
Outcome Measure:  The expected outcomes of MBRS support and plans to evaluate 
these outcomes are outlined in applicants' funding proposals and they vary from 
institution to institution.  These outcomes will be peer-reviewed when grantees submit 
renewal applications at the end of their funding period, and they are one consideration in 
providing continued funding for a program. 
 
Ongoing Minority Training and Career Development 
 
Objective.  The goal of MORE's ongoing support for training and career development is to 
encourage minority students to pursue training for scientific careers and strengthen the research 
skills of minority students and faculty.  The wide range of opportunities provided by these 
programs allow for the participation of all types of institutions in the MORE programs, from 
2-year colleges to research-intensive institutions having doctoral programs. 
 
Action:  Encourage minority students to pursue training for scientific careers and 
strengthen the research skills of minority students and faculty through grants.    
 
Performance Measure:  Number of grants awarded for training and career development 
through several ongoing programs: 
 
RISE.   RISE seeks to enhance the research environment at minority-serving institutions 
through faculty and student development.  The overall goal is to increase the interest, 
skills, and competitiveness of students and faculty in pursuit of biomedical research 
careers.  The program offers support for faculty and student development activities, 
which can include on- or off-campus workshops, specialty courses, travel to scientific 
meetings, and research experiences at on- or off-campus laboratories.  Support is 
available for evaluation activities, as well.  RISE also offers some support for 
institutional development, which includes limited funds for the renovation or remodeling 
of existing facilities to provide space for an investigator to carry out developmental 
activities, limited equipment purchases, and the development of research courses.  
 
IMSD.   IMSD encourages domestic private and public educational institutions with fully 
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developed and funded research programs to initiate and/or expand innovative programs 
to improve the academic and research capabilities of underrepresented minority students 
and to facilitate their progress toward careers in biomedical research. The application 
may be directed toward the development of underrepresented minority scientists who are 
in any phase of their career development, from the undergraduate level through the Ph.D. 
Awards under this program use the institutional education project grant mechanism.  
 
MARC Training and Fellowships.  MARC supports special research training 
opportunities for students and faculty at educational institutions with substantial minority 
enrollments.  MARC programs also enable grantee institutions to develop and strengthen 
their biomedical research training capabilities.  As a result, these schools are able to 
interest students in, and prepare them for, pursuing doctoral study and biomedical 
research careers. 
 
MARC accomplishes these goals through Undergraduate Student Training in Academic 
Research (U*STAR) institutional grants, predoctoral fellowships, faculty predoctoral and 
senior fellowships, a visiting scientist program, and grants for MARC ancillary training 
activities.  Like MBRS, MARC announced one-time supplemental grants for 
communications and technology in FY 1998.  
 
In addition to the programs described above, MARC has formed relationships with 
professional scientific societies to develop innovative programs aimed at increasing the 
number of underrepresented minority biomedical scientists.  These societies include the 
American Society for Cell Biology, the American Society for Microbiology, the Society 
for Advancement of Chicanos and Native Americans in Science, and the Federation of 
American Societies for Experimental Biology.  With MARC support, the societies have 
sponsored activities that engage minority students and faculty members in the biomedical 
sciences, including visiting scientist programs, summer research opportunities, and 
scholarships enabling attendance at national scientific meetings and conferences. 
 
National Predoctoral Fellowships for Minorities.  NIGMS also participates in an 
NIH-wide program providing predoctoral fellowship support for minorities. The National 
Research Service Award Predoctoral Fellowship for Minority Students provides up to 
five years of support for research training leading to the Ph.D. or equivalent research 
degree; the combined M.D./Ph.D. degree; or other combined professional degree and 
research doctoral degree in the biomedical, behavioral sciences, or health services 
research.  These fellowships are designed to enhance the racial and ethnic diversity of the 
biomedical, behavioral, and health services research labor force in the United States.  
Accordingly, academic institutions are encouraged to identify and recruit students from 
underrepresented racial and ethnic groups who can apply for this fellowship. 
 
IRACDA.  In FY 1998, NIGMS announced a new program that is designed to facilitate 
the progress of postdoctoral candidates toward research and teaching careers in academia. 
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The Institutional Research and Academic Career Development Award (IRACDA) 
combines a traditional mentored postdoctoral research experience with an opportunity to 
develop teaching skills through mentored assignments at a minority serving institution 
(MSI).  The goals of the program are to provide a resource to motivate the next 
generation of scientists at MSIs and to promote linkages between research-intensive 
institutions and MSIs that can lead to further collaborations in research and teaching. 
 
Bridges to the Future.  One special initiative supported by NIGMS is the Bridges to the 
Future Program, which is co-sponsored by NIGMS and the National Center on Minority 
Health and Health Disparities.  The mission of the Bridges to the Future program is to 
make available to the biomedical science research enterprise and to the nation the 
intellectual talents of an increasing number of underrepresented minority group members.  
It does so by facilitating the transition of students from associate- to baccalaureate-degree 
granting institutions and from masters to doctoral degree-granting institutions.  The program 
promotes effective inter-institutional partnerships that lead to improvement in the quality 
and quantity of underrepresented minority students being trained as the next generation 
of scientists.  Examples of activities supported through the Bridges program include 
laboratory research experiences, mentoring and academic counseling programs, 
curriculum enrichment, visiting lectureships, and course development. 
 
Research Supplements for Underrepresented Minorities.  As part of an NIH-wide 
program, principal investigators holding NIGMS research grants may request 
supplemental funds to support minority scientists and students.  The aim of these 
supplements is to attract and encourage minority individuals to pursue biomedical 
research careers.  Any principal investigator at a domestic institution holding an active 
NIGMS research grant, program project grant, center grant, or cooperative agreement 
research program, with a reasonable period of research support (usually 2 years or more) 
remaining at the time of the supplemental award, is eligible to submit a request to 
NIGMS for an administrative supplement to the grant.  
 
Outcome Measure:   The expected long-term outcome of NIGMS's ongoing training 
and career development activities is greater participation of minority students in science.  
More specific goals and measures are outlined in applicants’ funding proposals and vary 
from institution to institution.  These outcomes will be peer-reviewed when grantees 
submit renewal applications at the end of their funding period, and they are one 
consideration in providing continued funding for a program. 
 
 
National Research Service Award (NRSA) Institutional Research Training Programs 
 
Objective.  Encourage minority students to pursue training for scientific careers and strengthen 
the research skills of minority students through traditional NRSA training programs.  All 
institute-supported training programs are required to establish acceptable minority recruitment 
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plans to encourage the participation of underrepresented minority students in traditional research 
training grants.   
 
Action:  Review the minority recruitment plans of all institute-supported training 
programs and ensure that they are acceptable.  These recruitment efforts are an integral 
part of the Institute's ongoing research training programs.  The costs of these efforts 
cannot be separated from NIGMS's total research training budget. 
 
Performance Measure:  Support for training and career development provided to only 
those institutions with acceptable minority recruitment plans. 
 
Outcome Measure:   Institutions' minority recruitment activities and progress are 
re-evaluated with each competing renewal application.  The expected long-term outcome 
of this support is greater participation of minority students in science.  NIGMS will 
monitor periodic assessments of the participation of minorities in science education and 
research performed by the National Science Foundation and the National Research 
Council.   
 
New Training and Career Development Initiatives 
 
Objective.   Maintain the interest of post-baccalaureate participants in scientific research and 
promote and instill an interest in research on health disparities.   
 
Action:  Fund a new NIGMS program, the Post-baccalaureate Research Education 
Program, to encourage underrepresented minority students who hold a baccalaureate 
degree in the biomedically-relevant sciences to pursue a research doctorate after 
postponing their application to graduate school.   
 
Performance Measure:   Announcement of program to the extramural community and 
number of grants awarded to institutions for support of post-baccalaureate students. 
 
Outcome Measure:  Participation in this program is expected to facilitate the 
development of a cohort of researchers who will address health problems 
disproportionately affecting minorities and the medically underserved. 
 
Objective.   Encourage research on diseases and health conditions of importance to American 
Indians and Alaska Natives, develop a cadre of American Indian biomedical and behavioral 
scientists and health professionals who are able to compete successfully for NIH funding, and 
increase the capacity of both the research-intensive organizations and the Indian organizations to 
work in partnership to produce competitive research proposals. 
 
Action:  Provide funding for centers that will link the Native American community with 
organizations that conduct health research.   
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Performance Measure:   Establishment of an interagency agreement with the Indian 
Health Service, and provision of support for this effort. 
 
Outcome Measure:  Support for this program is expected to result in the involvement of 
tribal organizations, research-intensive organizations, and Native American researchers 
in activities to stimulate research on diseases and health conditions of importance to 
American Indians and Alaska Natives, and to increase the quality of research proposals in 
these areas. 
 
 
COMMUNITY OUTREACH AND INFORMATION DISSEMINATION 
 
Outreach and Technical Assistance to Minority Serving Institutions.   
 
Rationale.  The recent restructuring of the MBRS program and new MORE initiatives resulted 
in an increase in the number and frequency of staff outreach visits to explain new program 
requirements, review incoming applications, and monitor ongoing programs.  In addition, 
NIGMS staff make presentations at regional workshops targeted at minority serving institutions 
not currently funded by NIGMS to introduce the workshop participants to NIH and NIGMS and 
familiarize them with the Institute's efforts to recruit minorities into science careers.  NIGMS 
has also provided technical assistance in writing grant applications for the RISE, MARC and 
Bridges to the Future programs.  A total of six workshops were held throughout the U.S. in fiscal 
year 2001.  NIGMS also provides outreach through several websites designed to provide 
information on ongoing NIGMS minority programs and initiatives.   In addition to staff outreach 
efforts, NIGMS provides extramural funding for technical assistance activities performed by 
third parties, such as professional societies.   
 
Objective.  The purpose of this outreach is to assist institutions in establishing specific goals for 
their programs, designing plans for assessing and reporting the outcomes of their programs, and 
developing their ability to compete successfully for MARC and MBRS support. 
 
Action Plan:  NIGMS will continue to provide technical assistance to minority-serving 
institutions.   
 
Performance Measure:  Continued support for staff visits to minority-serving 
institutions, development of workshops for potential applicants, and performance of other 
communication activities at research conferences and workshops. 
 
Outcome Measure:  Support for technical assistance is expected to result in the 
involvement of minority-serving institutions in activities to develop their ability to 
successfully compete for MARC and MBRS support and strengthen their own evaluation 
processes. 
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The Pharmacogenetics Populations Advisory Group 
 
Rationale.  It is important and necessary to consider issues of stereotyping and stigmatization of 
communities, and any possible resulting harm to individuals (e.g. discrimination in access to 
various social benefits) that may arise from membership in an identified group.   
 
Objective.  Establish a way to consider possible areas of misunderstanding and the ramifications 
of pharmacogenetics research.  Continue a dialogue on the likely benefits and potential risks of 
pharmacogenetics research, and steps that can be taken to minimize those risks. 
 
Action Plan:  A Pharmacogenetics Population Advisory Group has been formed and will 
be supported in fiscal years 2002 through 2006. 
 
Performance Measure:  Meetings of the advisory group held twice yearly. 
 
Outcome Measure:  Outcomes of this support will be an expanded role of the NIGMS 
Pharmacogenetics Populations Advisory Group, in conjunction with the 
Pharmacogenetics Research Network and Database, and bi-directional exchange of ideas 
and advice between members of the Advisory Group, or their designees, and 
collaborative centers funded through the Pharmacogenetics Research Network and 
Knowledge Base.   
 
 
Ethical, Legal, and Social Issues in Genetic Research 
 
Rationale.  It is recognized that people of different ethnic and geographic backgrounds may 
have different alleles of genes that predispose them to complex genetic disorders, and identifying 
such genes would be valuable for diagnosis and development of therapies.  However, studies on 
members of specific populations raise the possibility of discrimination, stigmatization, and 
stereotyping. 
 
Objective.  NIGMS has taken the lead in efforts to develop approaches that would permit 
investigators to conduct these important genetic studies while protecting the subjects and the 
populations from which they come from negative impact.   
 
Action Plan:  NIGMS held a meeting in July 1999 that led to the concept of special 
oversight groups that would assure that tissue samples are acquired and studied with due 
protections for the population.  A large, follow-up meeting was held in the summer of 
2000, and more regional meetings are planned in fiscal years 2002-2006 to seek input and 
advice from members of various ethnic groups.   
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Performance Measure:  Continued support for regional meetings and the receipt of 
input and advice from members of population subgroups. 
 
Outcome Measure.  The outcome of these efforts will be greater understanding among 
researchers and subject populations, and the protection of subjects from any negative 
impacts in future genetic research studies. 
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   NIGMS Health Disparities Budget   
   (Dollars in Millions)   
        
        
FY 2002 FY 2003 
Institute/Center 
 
Research Infrastructure Outreach Research Infrastructure Outreach 
NIGMS $16.80 $152.50 $0.10 $17.10 $163.20 $0.10 
 
